z-logo
open-access-imgOpen Access
A novel drug of elotuzumab for treatment of refractory/relapsed multiple myeloma: a meta-analysis of eight trials
Author(s) -
Lin Zhang,
Ding Jie-wei
Publication year - 2017
Publication title -
journal of chinese pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 12
ISSN - 1003-1057
DOI - 10.5246/jcps.2017.07.059
Subject(s) - multiple myeloma , refractory (planetary science) , oncology , medicine , meta analysis , drug , lenalidomide , pharmacology , materials science , composite material

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom